Drug Approval | April 18, 2022
Amneal achieves second U.S. biosimilars approval with Alymsys
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
This product will be manufactured at Lupin’s Nagpur facility in India
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
Subscribe To Our Newsletter & Stay Updated
